TabacaleraYsidron Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

TabacaleraYsidron General Information

Description

Mount TAM Biotechnologies Inc is a biopharmaceutical company operating in the US. Its core business is to optimize, develop a portfolio of products focused on improving the health and wellbeing of individuals afflicted with serious diseases, with a key product targeting systemic lupus erythematosus (SLE) and a strategy to bring to market novel therapeutics across a range of serious disease areas. The company mainly focuses on the development of a product candidate in the field of SLE, an autoimmune disorder where treatments are inadequate to control disease and a condition where serious unmet need remains. It product candidates is TAM-01 and TAM-03 which are novel rapalogs in action of binding and inhibition of the mammalian Target of Rapamycin.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 100 Europa Drive
  • Suite 455
  • Chapel Hill, NC 27517
  • United States
Primary Industry
Other Consumer Non-Durables
Acquirer
Mount Tam Biotechnologies
Vertical(s)
Manufacturing
Corporate Office
  • 100 Europa Drive
  • Suite 455
  • Chapel Hill, NC 27517
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TabacaleraYsidron Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TabacaleraYsidron‘s full profile, request access.

Request a free trial

TabacaleraYsidron Acquisitions (1)

TabacaleraYsidron’s most recent deal was a Reverse Merger with Mount Tam Biotechnologies. The deal was made on 14-Aug-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mount Tam Biotechnologies 14-Aug-2015 Reverse Merger Pharmaceuticals
To view TabacaleraYsidron’s complete acquisitions history, request access »

TabacaleraYsidron FAQs

  • When was TabacaleraYsidron founded?

    TabacaleraYsidron was founded in 2011.

  • Where is TabacaleraYsidron headquartered?

    TabacaleraYsidron is headquartered in Chapel Hill, NC.

  • What industry is TabacaleraYsidron in?

    TabacaleraYsidron’s primary industry is Other Consumer Non-Durables.

  • Is TabacaleraYsidron a private or public company?

    TabacaleraYsidron is a Private company.

  • What is TabacaleraYsidron’s current revenue?

    The current revenue for TabacaleraYsidron is .

  • How much funding has TabacaleraYsidron raised over time?

    TabacaleraYsidron has raised $549K.

  • When was TabacaleraYsidron acquired?

    TabacaleraYsidron was acquired on 13-Aug-2015.

  • Who acquired TabacaleraYsidron?

    TabacaleraYsidron was acquired by Mount Tam Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »